Praxis Precision Medicines, Inc.
PRAX
$305.00
$11.053.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 17.80% | 4.43% | |||
| Gross Profit | -17.80% | -4.43% | |||
| SG&A Expenses | 55.53% | -3.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.85% | 3.01% | |||
| Operating Income | -23.85% | -3.01% | |||
| Income Before Tax | -20.26% | -3.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -20.26% | -3.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -20.26% | -3.95% | |||
| EBIT | -23.85% | -3.01% | |||
| EBITDA | -23.84% | -3.05% | |||
| EPS Basic | -4.02% | -1.57% | |||
| Normalized Basic EPS | -8.22% | -1.57% | |||
| EPS Diluted | -4.02% | -1.57% | |||
| Normalized Diluted EPS | -8.22% | -1.57% | |||
| Average Basic Shares Outstanding | 15.61% | 2.34% | |||
| Average Diluted Shares Outstanding | 15.61% | 2.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||